Phibro Animal Health Co. (NASDAQ:PAHC) to Issue $0.12 Quarterly Dividend

Phibro Animal Health Co. (NASDAQ:PAHC) announced a quarterly dividend on Tuesday, February 4th,RTT News reports. Shareholders of record on Wednesday, March 5th will be paid a dividend of 0.12 per share on Wednesday, March 26th. This represents a $0.48 dividend on an annualized basis and a yield of 2.18%.

Phibro Animal Health has a dividend payout ratio of 25.7% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Phibro Animal Health to earn $1.92 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 25.0%.

Phibro Animal Health Stock Up 1.5 %

Shares of Phibro Animal Health stock traded up $0.33 on Tuesday, hitting $22.02. 86,453 shares of the company’s stock traded hands, compared to its average volume of 140,820. Phibro Animal Health has a 52-week low of $10.03 and a 52-week high of $25.98. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. The stock has a market cap of $891.81 million, a P/E ratio of 51.21, a PEG ratio of 0.56 and a beta of 0.52. The firm’s 50-day moving average is $21.98 and its 200 day moving average is $21.56.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.35 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.12. The company had revenue of $260.40 million during the quarter, compared to analyst estimates of $277.76 million. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%. During the same period last year, the business earned $0.14 EPS. Equities analysts anticipate that Phibro Animal Health will post 1.62 earnings per share for the current year.

Wall Street Analysts Forecast Growth

PAHC has been the subject of several research reports. Barclays lifted their target price on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 12th. StockNews.com raised shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a report on Wednesday, January 29th. Finally, Morgan Stanley increased their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $20.50.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.